Research programme: Mitophagy stimulants - Vandria
Alternative Names: Mitochondrial therapeutics - Vandria; Mitophagy inducers - VandriaLatest Information Update: 16 Jan 2023
At a glance
- Originator Vandria
- Class Small molecules
- Mechanism of Action Autophagy stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 16 Dec 2022 Early research in Unspecified in Switzerland (unspecified route) prior to December 2022 (Vandria pipeline, December 2022)